BridgeMD
Compares treatment options for Primary Total Hip Arthroplasty
Official title Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty
ClinicalTrials.gov ID: NCT07337642
What this study is testing
- What it's testing
- This is a prospective randomized control trial comparing two collared and collarless femoral implants used in primary total hip arthroplasty. The specific aims of this trial are to: SA1: Prospectively assess clinical outcomes in patients undergoing primary total hip arthroplasty with a collared versus collarless femoral stem of the same design.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 99
You may be able to join if
- Adults (≥ 18 years old) scheduled for primary, uncemented THA using a cementless femoral stem
- Diagnosis of primary osteoarthritis or other non-inflammatory degenerative joint disease.
- Ability and willingness to comply with study procedures and follow-up schedule.
- Ability to provide written informed consent
You likely can't join if
- Patients not indicated for a cementless THA
- Prior surgery on the ipsilateral hip (e.g., prior THA, internal fixation, osteotomy)
- Use of cemented or hybrid femoral components.
- Revision THA or conversion THA
- Active or prior infection of the hip joint.
- Severe osteoporosis (T-score ≤ -2.5) or known metabolic bone disease.
See the full eligibility criteria
- Adults (≥ 18 years old) scheduled for primary, uncemented THA using a cementless femoral stem
- Diagnosis of primary osteoarthritis or other non-inflammatory degenerative joint disease.
- Ability and willingness to comply with study procedures and follow-up schedule.
- Ability to provide written informed consent
- Patients not indicated for a cementless THA
- Prior surgery on the ipsilateral hip (e.g., prior THA, internal fixation, osteotomy)
- Use of cemented or hybrid femoral components.
- Revision THA or conversion THA
- Active or prior infection of the hip joint.
- Severe osteoporosis (T-score ≤ -2.5) or known metabolic bone disease.
- Inability to complete follow-up or anticipated relocation out of the area.
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 99 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.